Abstract
The osteochondral tissue represents a complex structure composed of four interconnected structures, namely hyaline cartilage, a thin layer of calcified cartilage, subchondral bone, and cancellous bone. Due to the several difficulties associated with its repair and regeneration, researchers have developed several studies aiming to restore the native tissue, some of which had led to tissue-engineered commercial products. In this sense, this chapter discusses the good manufacturing practices, regulatory medical conditions and challenges on clinical translations that should be fulfilled regarding the safety and efficacy of the new commercialized products. Furthermore, we review the current osteochondral products that are currently being marketed and applied in the clinical setting, emphasizing the advantages and difficulties of each one.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Bose S, Roy M, Bandyopadhyay A (2012) Recent advances in bone tissue engineering scaffolds. Trends Biotechnol 30:546–554. https://doi.org/10.1016/j.tibtech.2012.07.005
Benders KEM, van Weeren PR, Badylak SF et al (2013) Extracellular matrix scaffolds for cartilage and bone regeneration. Trends Biotechnol 31:169–176. https://doi.org/10.1016/j.tibtech.2012.12.004
Oliveira JT, Reis RL (2011) Polysaccharide-based materials for cartilage tissue engineering applications. J Tissue Eng Regen Med 5:421–436. https://doi.org/10.1002/term.335
Ge Z, Jin Z, Cao T (2008) Manufacture of degradable polymeric scaffolds for bone regeneration. Biomed Mater 3:22001. https://doi.org/10.1088/1748-6041/3/2/022001
Karageorgiou V, Kaplan D (2005) Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 26:5474–5491. https://doi.org/10.1016/j.biomaterials.2005.02.002
Habibovic P, Yuan H, van der Valk CM et al (2005) 3D microenvironment as essential element for osteoinduction by biomaterials. Biomaterials 26:3565–3575. https://doi.org/10.1016/j.biomaterials.2004.09.056
Pina S, Oliveira JM, Reis RL (2015) Natural-based nanocomposites for bone tissue engineering and regenerative medicine: a review. Adv Mater 27:1143–1169. https://doi.org/10.1002/adma.201403354
Canadas RF, Pina S, Marques AP et al (2016) Cartilage and bone regeneration—how close are we to bedside? In: Transl. Regen. Med. to Clin. Elsevier, Amsterdam, pp 89–106
Giannoudis PV, Dinopoulos H, Tsiridis E (2005) Bone substitutes: an update. Injury 36:S20–S27. https://doi.org/10.1016/j.injury.2005.07.029
Van Norman GA (2016) Drugs and devices: comparison of European and U.S. approval processes. JACC Basic Transl Sci 1:399–412. https://doi.org/10.1016/j.jacbts.2016.06.003
Webber MJ, Khan OF, Sydlik SA et al (2014) A perspective on the clinical translation of scaffolds for tissue engineering. Ann Biomed Eng 43:641–656. https://doi.org/10.1007/s10439-014-1104-7
Dodson BP, Levine AD (2015) Challenges in the translation and commercialization of cell therapies. BMC Biotechnol 15:70. https://doi.org/10.1186/s12896-015-0190-4
Basu J, Ludlow JW (2012) Regulatory and quality control. Dev Tissue Eng Regen Med Prod A Pract Approach 125–148. https://doi.org/10.1533/9781908818119.125
Idowu B, Di Silvio L (2013) Principles of good laboratory practice (GLP) for in vitro cell culture applications. Stand Cell Tissue Eng Methods Protoc 127–147. https://doi.org/10.1533/9780857098726.2.127
Gálvez P, Clares B, Hmadcha A et al (2013) Development of a cell-based medicinal product: regulatory structures in the European Union. Br Med Bull 105:85–105. https://doi.org/10.1093/bmb/lds036
Tyler RS (2013) The goals of FDA regulation and the challenges of meeting them. Health Matrix Clevel 22:423–431
Lewin A (2012) Medical device innovation in America: tensions between food and drug law and patent law. Harv J Law Technol 26
Dormer NH, Berkland CJ, Detamore MS (2010) Emerging techniques in stratified designs and continuous gradients for tissue engineering of interfaces. Ann Biomed Eng 38:2121–2141. https://doi.org/10.1007/s10439-010-0033-3
Elguizaoui S, Flanigan DC, Harris JD et al (2012) Proud osteochondral autograft versus synthetic plugs—contact pressures with cyclical loading in a bovine knee model. Knee 19:812–817. https://doi.org/10.1016/j.knee.2012.03.008
Swieszkowski W, Tuan BHS, Kurzydlowski KJ, Hutmacher DW (2007) Repair and regeneration of osteochondral defects in the articular joints. Biomol Eng 24:489–495. https://doi.org/10.1016/j.bioeng.2007.07.014
Schaefer D, Martin I, Jundt G et al (2002) Tissue-engineered composites for the repair of large osteochondral defects. Arthritis Rheum 46:2524–2534. https://doi.org/10.1002/art.10493
Getgood A, Henson F, Skelton C et al (2014) Osteochondral tissue engineering using a biphasic collagen/GAG scaffold containing rhFGF18 or BMP-7 in an ovine model. J Exp Orthop 1:13. https://doi.org/10.1186/s40634-014-0013-x
Kon E, Delcogliano M, Filardo G et al (2009) Novel nano-composite multi-layered biomaterial for the treatment of multifocal degenerative cartilage lesions. Knee Surg Sport Traumatol Arthrosc 17:1312–1315. https://doi.org/10.1007/s00167-009-0819-8
Kon E, Delcogliano M, Filardo G et al (2010) Orderly osteochondral regeneration in a sheep model using a novel nano-composite multilayered biomaterial. J Orthop Res 28:n/a. https://doi.org/10.1002/jor.20958
Christensen BB, Foldager CB, Jensen J et al (2016) Poor osteochondral repair by a biomimetic collagen scaffold: 1- to 3-year clinical and radiological follow-up. Knee Surg Sport Traumatol Arthrosc 24:2380–2387. https://doi.org/10.1007/s00167-015-3538-3
Ishikawa M, Yoshioka K, Urano K et al (2014) Biocompatibility of cross-linked hyaluronate (Gel-200) for the treatment of knee osteoarthritis. Osteoarthr Cartil 22:1902–1909. https://doi.org/10.1016/j.joca.2014.08.002
Strand V, Baraf HSB, Lavin PT et al (2012) A multicenter, randomized controlled trial comparing a single intra-articular injection of Gel-200,?a?new cross-linked formulation of hyaluronic acid, to phosphate buffered saline for treatment of osteoarthritis of the knee. Osteoarthr Cartil 20:350–356. https://doi.org/10.1016/j.joca.2012.01.013
Stanish WD, McCormack R, Forriol F et al (2013) Novel scaffold-based BST-CarGel treatment results in superior cartilage repair compared with microfracture in a randomized controlled trial. J Bone Jt Surg Am 95:1640–1650. https://doi.org/10.2106/JBJS.L.01345
Shive MS, Hoemann CD, Restrepo A et al (2006) BST-CarGel: in situ chondroinduction for cartilage repair. Oper Tech Orthop 16:271–278. https://doi.org/10.1053/j.oto.2006.08.001
Shive MS, Stanish WD, McCormack R et al (2015) BST-CarGel® treatment maintains cartilage repair superiority over microfracture at 5 years in a multicenter randomized controlled trial. Cartilage 6:62–72. https://doi.org/10.1177/1947603514562064
Erggelet C, Endres M, Neumann K et al (2009) Formation of cartilage repair tissue in articular cartilage defects pretreated with microfracture and covered with cell-free polymer-based implants. J Orthop Res 27:1353–1360. https://doi.org/10.1002/jor.20879
Siclari A, Mascaro G, Gentili C et al (2014) Cartilage repair in the knee with subchondral drilling augmented with a platelet-rich plasma-immersed polymer-based implant. Knee Surg Sport Traumatol Arthrosc 22:1225–1234. https://doi.org/10.1007/s00167-013-2484-1
Becher C, Ettinger M, Ezechieli M et al (2015) Repair of retropatellar cartilage defects in the knee with microfracture and a cell-free polymer-based implant. Arch Orthop Trauma Surg 135:1003–1010. https://doi.org/10.1007/s00402-015-2235-5
McNickle AG, Provencher MT, Cole BJ (2008) Overview of Existing Cartilage Repair Technology. Sports Med Arthrosc 16:196–201. https://doi.org/10.1097/JSA.0b013e31818cdb82
Falez F, Sciarretta FV (2015) Treatment of osteochondral symptomatic defects of the knee with salucartilage. Orthop Proc 87-B
Lange J, Follak N, Nowotny T, Merk H (2006) Ergebnisse der SaluCartilage-implantation bei viertgradigen Knorpelschäden im Bereich des Kniegelenks. Unfallchirurg 109:193–199. https://doi.org/10.1007/s00113-005-1025-x
Ishaug-Riley SL, Crane-Kruger GM, Yaszemski MJ, Mikos AG (1998) Three-dimensional culture of rat calvarial osteoblasts in porous biodegradable polymers. Biomaterials 19:1405–1412. https://doi.org/10.1016/S0142-9612(98)00021-0
Demoor M, Ollitrault D, Gomez-Leduc T et al (2014) Cartilage tissue engineering: Molecular control of chondrocyte differentiation for proper cartilage matrix reconstruction. Biochim Biophys Acta Gen Subj 1840:2414–2440. https://doi.org/10.1016/j.bbagen.2014.02.030
Barnewitz D, Endres M, Krüger I et al (2006) Treatment of articular cartilage defects in horses with polymer-based cartilage tissue engineering grafts. Biomaterials 27:2882–2889. https://doi.org/10.1016/j.biomaterials.2006.01.008
Kreuz PC, Müller S, Ossendorf C et al (2009) Treatment of focal degenerative cartilage defects with polymer-based autologous chondrocyte grafts: four-year clinical results. Arthritis Res Ther 11:R33. https://doi.org/10.1186/ar2638
Ossendorf C, Kaps C, Kreuz PC et al (2007) Treatment of posttraumatic and focal osteoarthritic cartilage defects of the knee with autologous polymer-based three-dimensional chondrocyte grafts: 2-year clinical results. Arthritis Res Ther 9:R41. https://doi.org/10.1186/ar2180
Guillemin G, Patat J-L, Fournie J, Chetail M (1987) The use of coral as a bone graft substitute. J Biomed Mater Res 21:557–567. https://doi.org/10.1002/jbm.820210503
Kon E, Filardo G, Shani J et al (2015) Osteochondral regeneration with a novel aragonite-hyaluronate biphasic scaffold: up to 12-month follow-up study in a goat model. J Orthop Surg Res 10:81. https://doi.org/10.1186/s13018-015-0211-y
Zhong SP, Campoccia D, Doherty PJ et al (1994) Biodegradation of hyaluronic acid derivatives by hyaluronidase. Biomaterials 15:359–365
Campoccia D, Doherty P, Radice M et al (1998) Semisynthetic resorbable materials from hyaluronan esterification. Biomaterials 19:2101–2127. https://doi.org/10.1016/S0142-9612(98)00042-8
Iii RJW, Gamradt SC, Williams RJ (2008) Articular cartilage repair using a resorbable matrix scaffold. Instr Course Lect 57:563–571
Melton JT, Wilson AJ, Chapman-Sheath P, Cossey AJ (2010) TruFit CB ® bone plug: chondral repair, scaffold design, surgical technique and early experiences. Expert Rev Med Devices 7:333–341. https://doi.org/10.1586/erd.10.15
Carmont MR, Carey-Smith R, Saithna A et al (2009) Delayed Incorporation of a TruFit Plug: perseverance is recommended. Arthrosc J Arthrosc Relat Surg 25:810–814. https://doi.org/10.1016/j.arthro.2009.01.023
Hindle P, Hendry JL, Keating JF, Biant LC (2014) Autologous osteochondral mosaicplasty or TruFit® plugs for cartilage repair. Knee Surg Sport Traumatol Arthrosc 22:1235–1240. https://doi.org/10.1007/s00167-013-2493-0
Kon E, Filardo G, Perdisa F et al (2014) Clinical results of multilayered biomaterials for osteochondral regeneration. J Exp Orthop 1:10. https://doi.org/10.1186/s40634-014-0010-0
Buda R, Vannini F, Castagnini F et al (2015) Regenerative treatment in osteochondral lesions of the talus: autologous chondrocyte implantation versus one-step bone marrow derived cells transplantation. Int Orthop 39:893–900. https://doi.org/10.1007/s00264-015-2685-y
Worthen J, Waterman BR, Davidson PA, Lubowitz JH (2012) Limitations and sources of bias in clinical knee cartilage research. Arthrosc J Arthrosc Relat Surg 28:1315–1325. https://doi.org/10.1016/j.arthro.2012.02.022
Bertolo A, Mehr M, Aebli N et al (2012) Influence of different commercial scaffolds on the in vitro differentiation of human mesenchymal stem cells to nucleus pulposus-like cells. Eur Spine J 21(Suppl 6):S826–S838. https://doi.org/10.1007/s00586-011-1975-3
Chen RR, Mooney DJ (2003) Polymeric growth factor delivery strategies for tissue engineering. Pharm Res 20:1103–1112. https://doi.org/10.1023/A:1025034925152
Ammerman JM, Libricz J, Ammerman MD (2013) The role of Osteocel Plus as a fusion substrate in minimally invasive instrumented transforaminal lumbar interbody fusion. Clin Neurol Neurosurg 115:991–994. https://doi.org/10.1016/j.clineuro.2012.10.013
McAllister BS (2011) Stem cell-containing allograft matrix enhances periodontal regeneration: case presentations. Int J Periodontics Restorative Dent 31:149–155
Scott RT, Hyer CF (2013) Role of cellular allograft containing mesenchymal stem cells in high-risk foot and ankle reconstructions. J Foot Ankle Surg 52:32–35. https://doi.org/10.1053/j.jfas.2012.09.004
Dhandayuthapani B, Yoshida Y, Maekawa T, Kumar DS (2011) Polymeric scaffolds in tissue engineering application: a review. Int J Polym Sci. https://doi.org/10.1155/2011/290602
Drosos GI (2015) Use of demineralized bone matrix in the extremities. World J Orthop 6:269. https://doi.org/10.5312/wjo.v6.i2.269
Abrams GD, Mall NA, Fortier LA et al (2013) BioCartilage: background and operative technique. Oper Tech Sports Med 21:116–124. https://doi.org/10.1053/j.otsm.2013.03.008
Kurkijärvi JE, Mattila L, Ojala RO et al (2007) Evaluation of cartilage repair in the distal femur after autologous chondrocyte transplantation using T2 relaxation time and dGEMRIC. Osteoarthr Cartil 15:372–378. https://doi.org/10.1016/j.joca.2006.10.001
Gobbi A, Kon E, Berruto M et al (2009) Patellofemoral full-thickness chondral defects treated with second-generation autologous chondrocyte implantation. Am J Sports Med 37:1083–1092. https://doi.org/10.1177/0363546509331419
Marcacci M, Berruto M, Brocchetta D, et al (2005) Articular cartilage engineering with hyalograft(R) C: 3-year clinical results. [Report]. Clin Orthop Relat Res 96–105
Tompkins M, Adkisson HD, Bonner KF (2013) DeNovo NT allograft. Oper Tech Sports Med 21:82–89. https://doi.org/10.1053/j.otsm.2013.03.005
Kruse DL, Ng A, Paden M, Stone PA (2012) Arthroscopic de novo NT? juvenile allograft cartilage implantation in the talus: a case presentation. J Foot Ankle Surg 51:218–221. https://doi.org/10.1053/j.jfas.2011.10.027
Buckwalter JA, Bowman GN, Albright JP et al (2014) Clinical outcomes of patellar chondral lesions treated with juvenile particulated cartilage allografts. Iowa Orthop J 34:44–49
Gomoll AH (2013) Osteochondral allograft transplantation using the chondrofix implant. Oper Tech Sports Med 21:90–94. https://doi.org/10.1053/j.otsm.2013.03.002
Reynolds KL, Bishai SK (2014) In situ evaluation of chondrofix(registered trademark) osteochondral allograft 25 months following implantation: a case report. Osteoarthr Cartil 22:S155–S156. https://doi.org/10.1016/j.joca.2014.02.288
Horton MT, Pulido PA, McCauley JC, Bugbee WD (2013) Revision osteochondral allograft transplantations. Am J Sports Med 41:2507–2511. https://doi.org/10.1177/0363546513500628
Acknowledgments
The authors acknowledge the project FROnTHERA (NORTE-01-0145-FEDER-000023), supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF). The authors would also like to acknowledge H2020-MSCA-RISE program, as this work is part of developments carried out in BAMOS project, funded by the European Union’s Horizon 2020 research and innovation program under grant agreement N° 734156. The financial support from the Portuguese Foundation for Science and Technology under the program Investigador FCT 2012 and 2015 (IF/00423/2012 and IF/01285/2015) is also greatly acknowledged.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Bicho, D., Pina, S., Reis, R.L., Oliveira, J.M. (2018). Commercial Products for Osteochondral Tissue Repair and Regeneration. In: Oliveira, J., Pina, S., Reis, R., San Roman, J. (eds) Osteochondral Tissue Engineering. Advances in Experimental Medicine and Biology, vol 1058. Springer, Cham. https://doi.org/10.1007/978-3-319-76711-6_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-76711-6_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-76710-9
Online ISBN: 978-3-319-76711-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)